Intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (OMS-I100)

Documenti analoghi

• Long-term overall survival from a phase I trial using intratumoral plasmid interleukin-12 with electroporation in patients with melanoma
  di: Daud, Adil, et al.
  Pubblicazione: (2015)
• Intratumoral plasmid IL-12 electroporation therapy in advanced melanoma patients induces systemic and intratumoral T cell responses: T cell responses induced by plasmid IL-12 electroporation
  di: Greaney, Samantha K., et al.
  Pubblicazione: (2019)
• Plasmid IL-12 electroporation in melanoma
  di: Cha, Edward, et al.
  Pubblicazione: (2012)
• Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma
  di: Daud, Adil I., et al.
  Pubblicazione: (2008)
• Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity
  di: Jack Y. Lee, et al.
  Pubblicazione: (2022-06-01)